Matches in Wikidata for { <http://www.wikidata.org/entity/Q81339530> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q81339530 description "artículu científicu espublizáu n'ochobre de 2005" @default.
- Q81339530 description "im Oktober 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81339530 description "scientific article published on 01 October 2005" @default.
- Q81339530 description "wetenschappelijk artikel" @default.
- Q81339530 description "наукова стаття, опублікована в жовтні 2005" @default.
- Q81339530 name "Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease" @default.
- Q81339530 name "Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease" @default.
- Q81339530 type Item @default.
- Q81339530 label "Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease" @default.
- Q81339530 label "Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease" @default.
- Q81339530 prefLabel "Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease" @default.
- Q81339530 prefLabel "Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease" @default.
- Q81339530 P1433 Q81339530-9283EA91-6EA0-492F-86CC-228B1EEA1880 @default.
- Q81339530 P1476 Q81339530-6ED206BF-9AC9-4BA2-917E-63F4BD1D44B2 @default.
- Q81339530 P2093 Q81339530-1655270C-2E18-448B-B128-650EE8342D72 @default.
- Q81339530 P2093 Q81339530-1EA53CBC-68B8-4CD8-9B60-8CA075839413 @default.
- Q81339530 P2093 Q81339530-48012024-E6DC-42AC-9261-7E49AB37E7C4 @default.
- Q81339530 P2093 Q81339530-66AC579B-5E7B-4123-805D-2A78558024B9 @default.
- Q81339530 P2093 Q81339530-7C2E522B-976B-4702-8871-8B2C37396740 @default.
- Q81339530 P2093 Q81339530-9F87D004-9A93-4D05-87CC-25CF45CB9E31 @default.
- Q81339530 P304 Q81339530-2275C0FD-B290-4932-9FD0-4294F7090A27 @default.
- Q81339530 P31 Q81339530-FA779664-FF65-40ED-9EEF-C7FFA10DFA44 @default.
- Q81339530 P356 Q81339530-FAF8592D-1381-4D56-981D-359435A5143B @default.
- Q81339530 P433 Q81339530-34B00314-6A49-49E2-943D-B40D2C18A82C @default.
- Q81339530 P478 Q81339530-400DD20D-19E4-4E11-A579-D6FE62813A58 @default.
- Q81339530 P577 Q81339530-0C7BBA53-8E62-4400-BBC0-BB7D7D90699B @default.
- Q81339530 P698 Q81339530-DD77D514-67E5-4A5D-8728-F60CC5CC7391 @default.
- Q81339530 P921 Q81339530-39AE0AF1-A990-4E19-B46E-09D793AB9090 @default.
- Q81339530 P921 Q81339530-7C54551C-9B07-4CD6-B096-97D153F7E179 @default.
- Q81339530 P921 Q81339530-963fec61-4855-5b24-4b60-c557f159f274 @default.
- Q81339530 P356 J.1492-7535.2005.01155.X @default.
- Q81339530 P698 16219057 @default.
- Q81339530 P1433 Q15757113 @default.
- Q81339530 P1476 "Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease" @default.
- Q81339530 P2093 "Eduardo Lacson" @default.
- Q81339530 P2093 "J Michael Lazarus" @default.
- Q81339530 P2093 "Janus Ong" @default.
- Q81339530 P2093 "Lori Vienneau" @default.
- Q81339530 P2093 "Ming Teng" @default.
- Q81339530 P2093 "Norma Ofsthun" @default.
- Q81339530 P304 "367-375" @default.
- Q81339530 P31 Q13442814 @default.
- Q81339530 P356 "10.1111/J.1492-7535.2005.01155.X" @default.
- Q81339530 P433 "4" @default.
- Q81339530 P478 "9" @default.
- Q81339530 P577 "2005-10-01T00:00:00Z" @default.
- Q81339530 P698 "16219057" @default.
- Q81339530 P921 Q1054718 @default.
- Q81339530 P921 Q113292210 @default.
- Q81339530 P921 Q6853 @default.